In early November, the inaugural Digital Medicine & DTx Global Policy Summit, part of Frontiers Health 2023, brought together experts, policymakers, and industry leaders from Europe, th
In this issue of Deep Dive, AXON’s Silvia De Carvalho details how generative AI is ushering in a new era of expedited, data-driven clinical research, experts from Research Partnership discu
In the ever-evolving realm of healthcare and pharmaceuticals, the intricate dance between innovation and investment shapes the trajectory of groundbreaking discoveries and patient-centric a
Patient centricity has been a key focus for pharma in 2023. However, extending beyond the merely discursive topic into sustained and tangible action at scale has been somewhat limited.
For many spin-outs and start-ups in the pharmaceutical space, a key step in getting their science into patients is teaming up with a larger pharmaceutical company.
For pharmaceutical companies and other healthcare stakeholders, it is imperative that they understand how patient experience and input needs to be captured, contextualised, and applied to t
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.